BERNSTEIN LAWRENCE R has a total of 29 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1991. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, environmental technology and foods and drinks are CHEVION MORDECHAI, SUMMA HEALTH SYSTEM and IRR INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Australia | 4 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 2 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Foods and drinks | |
#4 | Medical technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Object sterilising | |
#5 | Fodder | |
#6 | Heterocyclic compounds | |
#7 | Foods | |
#8 | Special foods | |
#9 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Bernstein Lawrence R | 29 |
#2 | Bucalo Louis R | 4 |
#3 | Sreedharan Sunil | 4 |
#4 | Schwendner Susan | 3 |
#5 | Wirtz Uwe F | 3 |
#6 | Allamneni Krishna P | 1 |
Publication | Filing date | Title |
---|---|---|
US2011318265A1 | Coupled identification and treatment of cancer | |
US2008292726A1 | Ophthalmic gallium compositions and methods of their use | |
US2008175922A1 | Ophthalmic gallium compositions and methods of their use | |
US2007098815A1 | Orally Administrable Gallium Compositions and Methods of Use | |
WO03053347A2 | Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections | |
AU1197601A | Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes, DNA viruses and retroviruses | |
CA2257875A1 | Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or immunologically mediated disorders | |
KR20000022264A | Topical administration of certain azaspiranes to prevent or treat skin conditions associated with hyperproliferation of skin cells and/or imm | |
US5258376A | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |